Skip to main content
. 2017 Jan-Feb;28(1):60–67. doi: 10.5830/CVJA-2016-070

Table 3. Univariate associations between echo predictors and 180-day death by diagnosis groups.

Hypertensive CMP (n = 338) Valvular (n = 217) Other (n = 399)
Hazard ratio Hazard ratio Hazard ratio Interaction
Echocardiographic parameter (95% CI) p-value (95% CI) p-value (95% CI) p-value p-value
LVEDD (mm) 0.98 (0.96–1.01) 0.25 1.01 (0.98–1.04) 0.47 1.02 (1.00–1.04) 0.12 0.17
LVESD (mm) 0.99 (0.96–1.01) 0.28 1.01 (0.99–1.04) 0.32 1.01 (0.99–1.03) 0.19 0.20
IVSTd (mm) 0.95 (0.85–1.06) 0.34 0.99 (0.89–1.09) 0.80 0.91 (0.84–1.00) 0.041 0.50
PWTd (mm)
≤ 9 mm 0.58 (0.42–0.80) 0.0011 0.79 (0.57–1.10) 0.32 0.82 (0.67–1.00) 0.072 0.30
> 9 mm 1.73 (1.16–2.59) 0.0011 1.38 (0.91– 2.11) 0.32 1.19 (0.88–1.62) 0.072 0.30
LV mass 1.00 (0.99–1.00) 0.097 1.00 (1.00–1.00) 0.85 1.00 (1.00–1.00) 0.62 0.36
LVEF (%), per 5% increment 1.00 (0.90–1.11) 0.99 0.95 (0.85–1.06) 0.36 0.93 (0.86–1.02) 0.11 0.59
Left atrial size (A-P) (mm) 0.99 (0.94–1.03) 0.52 1.01 (0.97–1.04) 0.79 0.99 (0.96–1.02) 0.63 0.79
Left atrial size (planimetry) mm2 1.00 (1.00–1.00) 0.70 1.00 (1.00–1.00) 0.78 1.00 (1.00–1.00) 0.34 0.72
E/A ratio, per doubling 1.03 (0.74–1.43) 0.89 2.07 (1.01–4.26) 0.049 1.13 (0.86–1.49) 0.38 0.21
E-wave deceleration time (ms) 1.00 (0.99–1.00) 0.23 1.00 (1.00–1.00) 0.42 1.00 (0.99–1.00) 0.15 0.68
MV A-wave duration 1.00 (0.99–1.01) 0.63 1.01 (1.00–1.01) 0.12 1.00 (0.99–1.01) 0.47 0.26
MV E/A ratio grades
Grade 1: impaired relaxation (reference group) (reference group) (reference group)
Grade 2: pseudonormal 1.63 (0.67–3.98) 0.50 0.82 (0.07–8.99) 0.14 2.71 (0.91–8.04) 0.20 0.27
Grade 3: restrictive filling 1.14 (0.50–2.61) 3.01 (0.40–22.68) 2.16 (0.76–6.15)

LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; IVSTd, interventricular septal thickness in diastole; PWTd, posterior wall thickness in diastole; LV, left ventricular; LVEF, left ventricular ejection fraction; A-P, antero-posterior; MV, mitral valve.

Heart rates are for an increment of one unit in the predictor unless otherwise noted. Valvular group defined as rheumatic heart disease or having severe mitral stenosis/regurgitation, aortic stenosis/regurgitation.